Inflammasome Logo JPEG.jpg


Inflammasome Therapeutics is a science-based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration, and type 2 diabetes.

The precise causes of these diseases are unknown; however, they share many of the same risk factors – smoking, obesity, hypertension, and age. They all are multifactorial diseases with multiple biochemical factors, many shared, contributing to their progression.